These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3032052)

  • 21. Binding subsites in human thrombins.
    Conery BG; Berliner LJ
    Biochemistry; 1983 Jan; 22(2):369-75. PubMed ID: 6297546
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombin receptor antagonists.
    Ruda EM; Scrutton MC; Tuffin DP; Manley PM
    Agents Actions Suppl; 1986; 20():77-86. PubMed ID: 3028107
    [No Abstract]   [Full Text] [Related]  

  • 23. Subtle differences in active site structure between bovine and human thrombins: ESR and fluorescence studies.
    Nienaber VL; Berliner LJ
    Thromb Haemost; 1991 Jan; 65(1):40-5. PubMed ID: 1850875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and molecular modelling of 1-amidinopiperidine thrombin inhibitors.
    Smolnikar I; Perdih A; Stegnar M; Prezelj A; Solmajer T; Urleb U; Obreza A
    Pharmazie; 2007 Apr; 62(4):243-54. PubMed ID: 17484277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of ulinastatin on alpha-thrombin and the activation of protein C and factor XIII induced by thrombin].
    Fukutake K; Mimura K; Shinozawa K; Fujiwara K; Kobayashi T; Yatsuhashi T; Fukutake K; Inaba H
    Rinsho Byori; 1989 Apr; 37(4):416-20. PubMed ID: 2746930
    [No Abstract]   [Full Text] [Related]  

  • 26. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
    Karle M; Knecht W; Xue Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A strategy for a rational approach to designing synthetic selective inhibitors.
    Hijikata-Okunomiya A; Okamoto S
    Semin Thromb Hemost; 1992 Jan; 18(1):135-49. PubMed ID: 1574714
    [No Abstract]   [Full Text] [Related]  

  • 30. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human alpha- and gamma-thrombin inhibition by trypsin inhibitors supports predictions from molecular graphics experiments.
    Sugawara Y; Birktoft JJ; Berliner LJ
    Semin Thromb Hemost; 1986 Jul; 12(3):209-12. PubMed ID: 3775387
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
    Krishnan R; Mochalkin I; Arni R; Tulinsky A
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):294-303. PubMed ID: 10713516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activation by alpha-thrombin is a receptor-mediated event.
    Harmon JT; Jamieson GA
    Ann N Y Acad Sci; 1986; 485():387-95. PubMed ID: 3032051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complexes of thrombin with proteins secreted by activated platelets.
    Detwiler TC; Chang AC; Speziale MV; Browne PC; Miller JJ; Chen K
    Semin Thromb Hemost; 1992 Jan; 18(1):60-6. PubMed ID: 1315454
    [No Abstract]   [Full Text] [Related]  

  • 37. Protease-activated receptors: development of agonists selective for receptors triggered by either thrombin (PAR1) or trypsin (PAR2).
    Kawabata A; Saifeddine M; al-Ani B; Hollenberg MD
    Proc West Pharmacol Soc; 1997; 40():49-51. PubMed ID: 9436211
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
    Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
    Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cell receptors of thrombin].
    Monastyrskiĭ VA; Birka II
    Ukr Biokhim Zh (1978); 1987; 59(4):108-18. PubMed ID: 2820096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical evidence for an apolar binding site near the catalytic center of human alpha-thrombin.
    Berliner LJ; Shen YY
    Biochemistry; 1977 Oct; 16(21):4622-6. PubMed ID: 199239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.